We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $455M
1-Year Est. Return 218.66%
This Fund
S&P 500
This Quarter Est. Return
+71.21%
1 Year Est. Return
+218.66%
3 Year Est. Return
+1,489.77%
5 Year Est. Return
+4,348.98%
10 Year Est. Return
+169,910.37%
AUM
$491M
AUM Growth
+$188M
Cap. Flow
+$45.5M
Cap. Flow %
9.28%
Top 10 Hldgs %
18.99%
Holding
156
New
44
Increased
44
Reduced
29
Closed
39

Sector Composition

Rank Sector Weight
1 Healthcare 23.1%
2 Technology 22.24%
3 Industrials 19.83%
4 Consumer Discretionary 16.89%
5 Financials 6.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FANG icon
51
Diamondback Energy
FANG
$54.8B
$4.34M 0.89%
+103,845
New +$4.24M
FIVN icon
52
FIVE9
FIVN
$2.59B
$4.33M 0.88%
39,122
-94,736
-71% -$9.22M
SEDG icon
53
SolarEdge
SEDG
$2.13B
$4.32M 0.88%
31,145
-27,495
-47% -$3.36M
KRTX
54
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$4.27M 0.87%
38,290
+23,280
+155% +$2.02M
RGEN icon
55
Repligen
RGEN
$9.92B
$4.26M 0.87%
34,481
-51,559
-60% -$6.07M
YETI icon
56
Yeti Holdings
YETI
$2.99B
$4.26M 0.87%
+99,720
New +$3M
ENPH icon
57
Enphase Energy
ENPH
$4.68B
$4.25M 0.87%
89,325
-65,217
-42% -$3.12M
NTRA icon
58
Natera
NTRA
$50.4B
$4.25M 0.87%
+85,160
New +$3.42M
RBC icon
59
RBC Bearings
RBC
$15.3B
$4.21M 0.86%
31,435
-14,551
-32% -$1.86M
KRNT icon
60
Kornit Digital
KRNT
$649M
$4.07M 0.83%
+76,150
New +$2.9M
BL icon
61
BlackLine
BL
$1.67B
$4.04M 0.82%
48,785
-5,605
-10% -$374K
BHVN
62
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$4.03M 0.82%
+55,055
New +$2.93M
HAIN icon
63
Hain Celestial
HAIN
$55.6M
$3.98M 0.81%
126,170
+63,620
+102% +$1.84M
ACAD icon
64
Acadia Pharmaceuticals
ACAD
$4.75B
$3.94M 0.8%
81,398
-6,868
-8% -$330K
MNTA
65
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$3.93M 0.8%
118,130
+50,630
+75% +$1.61M
VRNS icon
66
Varonis Systems
VRNS
$5.47B
$3.8M 0.77%
128,730
+22,260
+21% +$557K
ASTE icon
67
Astec Industries
ASTE
$947M
$3.7M 0.75%
+79,800
New +$3.27M
BJ icon
68
BJs Wholesale Club
BJ
$11.8B
$3.67M 0.75%
+98,485
New +$3.02M
TGTX icon
69
TG Therapeutics
TGTX
$8.54B
$3.66M 0.75%
187,795
+95,645
+104% +$1.54M
JBTM
70
JBT Marel
JBTM
$5.85B
$3.63M 0.74%
42,250
+22,565
+115% +$1.75M
NARI
71
DELISTED
Inari Medical, Inc. Common Stock
NARI
$3.58M 0.73%
+73,880
New +$3.53M
SGI
72
Somnigroup International
SGI
$13.8B
$3.56M 0.73%
198,000
-68,396
-26% -$981K
PRI icon
73
Primerica
PRI
$9.07B
$3.54M 0.72%
30,375
+11,430
+60% +$1.22M
SNBR
74
DELISTED
Sleep Number
SNBR
$3.4M 0.69%
+81,595
New +$2.59M
MPWR icon
75
Monolithic Power Systems
MPWR
$56.8B
$3.12M 0.64%
13,145
+6,107
+87% +$1.24M

Similar funds

Lisanti Capital Growth's Q2 2020 Portfolio in Review

As of Q2 2020, Lisanti Capital Growth held 156 positions worth $491M, up 62% from $303M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth deployed $45.5M of net new capital in Q2 2020, opening 44 new positions and adding to 44 existing holdings. Its largest new stake was Livongo Health, Inc. Common Stock: 138,705 shares worth $10.4M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was FIVE9, an estimated $9.22M trimmed.

  • Lisanti Capital Growth's largest Q2 2020 buy was Livongo Health, Inc. Common Stock: 138,705 shares worth $10.4M.
  • Lisanti Capital Growth added most to Patrick Industries in Q2 2020, an estimated $4.65M increase.
  • Lisanti Capital Growth's biggest Q2 2020 reduction was FIVE9, cutting an estimated $9.22M.
  • Lisanti Capital Growth fully exited FTI Consulting in Q2 2020, selling an estimated $6.26M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $491M portfolio in Q2 2020.
  • Lisanti Capital Growth opened 44 new positions and closed 39 in Q2 2020.
  • Lisanti Capital Growth's portfolio value rose 62% quarter-over-quarter to $491M.

Based on Lisanti Capital Growth's 13F filing for Q2 2020, filed 10 Aug 2020.